Tag Archives: Moderna drug induced antibodies in ‘all trial volunteers’

WASHINGTON: An experimental COVID-19 vaccine that is being developed by US biotech firm Moderna induced antibody responses against the coronavirus in all 45 participants of a human trial, a paper published Tuesday showed. Moderna had previously published “interim results” from its Phase 1 in the form of a press release on its website in May, which revealed the vaccine had …

Read More »